RecruitingNot ApplicableNCT06232447

Menthol, Inflammation, and Nicotine Transition Study

Effect of Menthol to Non-Menthol Cigarette Switching on Subclinical Inflammatory Biomarkers of Cardiovascular Health: Simulating a Menthol Cigarette Ban


Sponsor

Rosalind Franklin University of Medicine and Science

Enrollment

68 participants

Start Date

Mar 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.


Eligibility

Min Age: 21 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether menthol cigarettes — the kind with a minty flavor — affect inflammation in the body more than regular cigarettes, which could raise the risk of heart disease. Participants who smoke menthol cigarettes daily will switch to non-menthol (but otherwise identical) cigarettes for four weeks, and researchers will measure changes in blood markers of inflammation. Adults aged 21–85 who currently smoke at least 5 menthol cigarettes per day and have done so for at least one year may be eligible. Participation involves blood draws, a smartphone-based app to track mood and cravings, and study-provided cigarettes. This summary was generated with AI assistance and is intended to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCigarette Type Switching

Participants will be switched from smoking menthol cigarettes to non-menthol cigarettes for a period of four weeks


Locations(1)

Rosalind Franklin University of Medicine and Science

North Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06232447


Related Trials